{"anaemia": 3.48, "disease progression": 6.36, "febrile neutropenia": 26.25, "malignant neoplasm progression": 5.47, "myelosuppression": 20.59, "neuropathy peripheral": 11.46, "neutropenia": 6.85, "off label use": 2.92, "product use in unapproved indication": 6.31, "white blood cell count decreased": 10.14}